Such observations, along with the previous report that HIF enhanced EPO release and concomitantly increased erythropoiesis [1,23], imply that activation of HIF by modulating PHDs could be beneficial for patients with anemia and ischemia-related diseases. The gene discussed is EPO; the disease is anemia (phenotype).